CJC-1295 no DAC 5mg | Modified GRF (1-29) | ≥99% Purity (HPLC)
CJC-1295 no DAC (also known as Modified GRF 1-29) is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of GHRH with four strategic substitutions for enhanced stability and potency. Unlike the DAC version, this short-acting form provides pulsatile GH release without prolonged elevation, making it a preferred research tool for studying natural GH pulsatility patterns.
Research investigations have highlighted CJC-1295 no DAC’s ability to:
- Stimulate pulsatile endogenous growth hormone secretion
- Increase IGF-1 levels in a dose-dependent manner
- Support muscle protein synthesis and nitrogen retention
- Enhance recovery and tissue repair processes
- Promote lipolysis and fat metabolism
- Exhibit synergistic effects when combined with GHRP analogs (e.g., Ipamorelin, GHRP-6)
- Modulate sleep quality and recovery in preclinical models
CJC-1295 no DAC is extensively studied in endocrine, regenerative, and performance biology research for its role in mimicking physiological GH pulses and exploring growth hormone axis modulation.
For Research Use Only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Strictly intended for in vitro laboratory research by qualified professionals.
Specifications:
- Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Molecular Weight: 3367.9 Da
- Appearance: White lyophilized powder
- Purity: ≥99% (HPLC)
- Solubility: Water-soluble
- Storage: Lyophilized at -20°C; reconstituted at 2–8°C short-term. Protect from light and moisture.
Common Research Areas: Growth hormone pulsatility • IGF-1 pathways • Muscle hypertrophy • Fat metabolism • Recovery mechanisms • Endocrine signaling • Synergistic peptide combinations
Manufactured in the USA under strict quality controls for consistency and high purit
Reviews
There are no reviews yet.